Venous Thrombo-embolic Complication prévention in Pelvic Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
Pelvic fracture surgery are very high thrombotic risk surgery with about 10% to 50% venous thrombo embolic complications and 0.5% to 10% of pulmonary embolism. The ST JOSEPH's Hospital have almost 60 cases per year . Following a fatal pulmonary embolism per operatory the team has set up a venous exploratory protocol before surgery. This protocol includes a venous doppler ultrasound of lower limbs associated to a abdo pelvic scanner in the 48hours before surgery. The aim is to evaluate this new protocol efficacy on prevention of thrombo embolic complications in pelvic fracture surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2018
CompletedFirst Submitted
Initial submission to the registry
May 11, 2018
CompletedFirst Posted
Study publicly available on registry
May 24, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2019
CompletedOctober 3, 2019
July 1, 2019
1.2 years
May 11, 2018
October 2, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
major thrombo-embolic events
Day 10 after surgery
Study Arms (1)
VENOUS exploration
Interventions
venous echo doppler ultrasound and abdo pelvic scanner in the 48h before surgery
Eligibility Criteria
patient with pelvic surgery indication consulting surgeons
You may qualify if:
- pelvic fracture with surgery indication
- age above 18 years
You may not qualify if:
- pelvic fracture without surgery indication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
BONHOMME Stéphanie, MD
GHPSJ
- STUDY DIRECTOR
RIOUALLON Guillaume, MD
GHPSJ
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2018
First Posted
May 24, 2018
Study Start
February 13, 2017
Primary Completion
April 25, 2018
Study Completion
August 31, 2019
Last Updated
October 3, 2019
Record last verified: 2019-07